We are live on ! Find out more
HCMT

Highland Capital Management (Texas) Portfolio holdings

AUM $39M
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$51.2M
Cap. Flow
-$42.3M
Cap. Flow %
-2.33%
Top 10 Hldgs %
39.8%
Holding
418
New
93
Increased
57
Reduced
76
Closed
102

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Energy 13.19%
3 Utilities 12.98%
4 Healthcare 12.17%
5 Real Estate 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST icon
1
Vistra
VST
$50B
$226M 12.45%
9,066,502
-201,500
-2% -$4.64M
LORL
2
DELISTED
Loral Space and Communications, Inc.
LORL
$91.5M 5.05%
2,015,767
-46,591
-2% -$1.92M
AVYA
3
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$71.8M 3.96%
3,241,495
NXRT
4
NexPoint Residential Trust
NXRT
$666M
$68.4M 3.77%
2,060,258
-393,160
-16% -$12.2M
NXDT
5
NexPoint Diversified Real Estate Trust
NXDT
$234M
$65.1M 3.59%
1,846,086
+75,763
+4% +$1.71M
IWM icon
6
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$50.6M 2.79%
300,000
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$43.6M 2.41%
+150,000
New +$42.7M
ET icon
8
Energy Transfer Partners
ET
$70.1B
$37.3M 2.06%
2,141,101
-169,190
-7% -$3M
ARCH
9
DELISTED
Arch Resources, Inc.
ARCH
$36.2M 2%
410,624
-12,007
-3% -$1.04M
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$31.3M 1.73%
1,174,555
+474,735
+68% +$15.5M
INTC icon
11
Intel
INTC
$455B
$30.7M 1.69%
648,250
-133,400
-17% -$6.49M
HRTX icon
12
Heron Therapeutics
HRTX
$93.9M
$26.7M 1.48%
845,042
-58,815
-7% -$2.19M
PRTK
13
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$25.7M 1.42%
2,654,428
+736,550
+38% +$7.43M
XPO icon
14
XPO
XPO
$23.5B
$24.2M 1.34%
613,985
-52,045
-8% -$1.89M
BIO icon
15
Bio-Rad Laboratories Class A
BIO
$8.71B
$23.6M 1.3%
75,520
-6,645
-8% -$2.06M
V icon
16
Visa
V
$684B
$23.5M 1.3%
156,584
+5,000
+3% +$711K
WMB icon
17
Williams Companies
WMB
$87.5B
$22.3M 1.23%
819,759
+172,661
+27% +$5.01M
AMZN icon
18
Amazon
AMZN
$2.92T
$19.4M 1.07%
194,000
+56,000
+41% +$5.27M
MSFT icon
19
Microsoft
MSFT
$3.45T
$19.2M 1.06%
167,458
+37,300
+29% +$4.04M
EPD icon
20
Enterprise Products Partners
EPD
$82.3B
$18.7M 1.03%
650,366
-120,900
-16% -$3.49M
AAPL icon
21
Apple
AAPL
$4.54T
$18.3M 1.01%
324,800
+106,000
+48% +$5.52M
CIT
22
DELISTED
CIT Group Inc.
CIT
$17.9M 0.99%
345,966
-189,100
-35% -$10.1M
SKY icon
23
Champion Homes
SKY
$4.37B
$17.3M 0.96%
607,227
NERV icon
24
Minerva Neurosciences
NERV
$185M
$16.6M 0.91%
164,903
-48,821
-23% -$3.67M
MPLX icon
25
MPLX
MPLX
$59.3B
$16M 0.89%
462,763
-14,714
-3% -$527K

Similar funds

Highland Capital Management (Texas)'s Q3 2018 Portfolio in Review

As of Q3 2018, Highland Capital Management (Texas) held 418 positions worth $1.81B, up 2.9% from $1.76B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Highland Capital Management (Texas)'s Q3 2018 filing shows 93 new, 57 increased, 76 reduced and 102 closed positions. Its largest new stake was Adobe: 32,500 shares worth $8.77M. The largest sale was EOG Resources, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Energy and Utilities.

  • Highland Capital Management (Texas)'s largest Q3 2018 buy was Adobe: 32,500 shares worth $8.77M.
  • Highland Capital Management (Texas) added most to Portola Pharmaceuticals, Inc. in Q3 2018, an estimated $15.5M increase.
  • Highland Capital Management (Texas)'s biggest Q3 2018 reduction was EOG Resources, cutting an estimated $17.5M.
  • Highland Capital Management (Texas) fully exited Corporacion America in Q3 2018, selling an estimated $13.7M.
  • Highland Capital Management (Texas)'s ten largest holdings make up 40% of its $1.81B portfolio in Q3 2018.
  • Highland Capital Management (Texas) opened 93 new positions and closed 102 in Q3 2018.
  • Highland Capital Management (Texas)'s portfolio value rose 2.9% quarter-over-quarter to $1.81B.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2018, filed 14 Nov 2018.